EUVIMEDEUVIMED entdecken
Crossref

Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C

Maria Buti, Joost P H Drenth, Manuel Mendizabal, Paulo L Bittencourt, Sophie Metivier, Victor de Ledinghen, Thomas Reiberger iD, Carolina Freyre, Isidoro Narváez Rodríguez, Rocio González-Grande, Juan C Alados, Manuel Hernández-Guerra und 13 weitere

Liver International · 2025

DOI: 10.1111/liv.70275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Maria Buti und 24 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitari Vall d'Hebron, Barcelona, Spain. Hauptthemen laut MEDLINE: Hepatitis C. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Gilead Sciences Inc., Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims A major barrier to hepatitis C virus (HCV) elimination is the failure to ensure that individuals complete the HCV care cascade after they test positive for HCV RNA and/or antibody. Microelimination programmes support protocols that reengage patients with care/treatment. We describe 18 microelimination programmes aimed at identifying persons who were diagnosed but untreated/not cured and reconnecting them to care. Here, we report the programmes' effectiveness, identify key challenges and suggest best practices for future initiatives.

Methods

Pooled and individual programme data (available as of 31 January 2024) were assessed. Each programme had a retrospective phase in which medical/laboratory records were searched within a specified date range for patients who were positive for HCV antibody and/or RNA at last testing. In a prospective phase, programmes attempted to reengage these patients with care.

Results

Across the 18 programmes worldwide, 82 006 individuals were identified as eligible for follow‐up. Overall, 21 235 people were selected for attempted contact, and 5308 were relinked to care. In 17 programmes reporting treatment data, 51% (1513 of 2976) of relinked patients initiated treatment. Four programmes used innovative care models and achieved treatment initiation rates ≥ 80%. Amongst patients with results available, 89% (643 of 722) who initiated treatment achieved HCV cure. Challenges included the inability to contact people and missed appointments.

Conclusion

Systematic screening of medical/laboratory records was effective in identifying patients who had been lost to follow‐up, and the use of innovative care models, such as test‐and‐treat or decentralised approaches, resulted in higher treatment numbers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHumansRetrospective StudiesMaleFemaleAntiviral AgentsHepacivirusHepatitis C AntibodiesMiddle AgedRNA, ViralProspective StudiesProgram EvaluationAdult

Stichwörter der Autor:innen

antiviral agentsdelivery of healthcarehepatitis Chepatitis C, chroniclost to follow‐upvulnerable populations

Substanzen

Antiviral AgentsHepatitis C AntibodiesRNA, Viral

Autor:innen und Institutionen

  • Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Unidad de Hígado y Trasplante Hepático, Hospital Universitario Austral, Buenos Aires, Argentina.
  • Bahiana School of Medicine and Public Health (BAHIANA), Salvador, Bahia, Brazil.
  • Portuguese Hospital, Salvador, Bahia, Brazil.
  • Service d'Hépatologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

ORCID-Profile: Thomas Reiberger

Förderung

  • Gilead Sciences Inc.
  • Gilead Sciences

Zitieren

APA

Buti, M., Drenth, J. P. H., Mendizabal, M., Bittencourt, P. L., Metivier, S., de Ledinghen, V., Reiberger, T., Freyre, C., Rodríguez, I. N., González-Grande, R., Alados, J. C., Hernández-Guerra, M., Dröse, S., Remy, A. J., Morillas, R. M., Vera, F., Martin, P. M., Romero, G., Scherbakovsky, S., …, & Branch, A. D. (2025). Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C. Liver International. https://doi.org/10.1111/liv.70275

Vancouver

Buti M, Drenth JPH, Mendizabal M, Bittencourt PL, Metivier S, de Ledinghen V, et al. Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C. Liver International. 2025. doi:10.1111/liv.70275

BibTeX
@article{Buti2025,
  author = {Buti, Maria and Drenth, Joost P H and Mendizabal, Manuel and Bittencourt, Paulo L and Metivier, Sophie and de Ledinghen, Victor and Reiberger, Thomas and Freyre, Carolina and Rodríguez, Isidoro Narváez and González-Grande, Rocio and Alados, Juan C and Hernández-Guerra, Manuel and Dröse, Sandra and Remy, André-Jean and Morillas, Rosa M and Vera, Francisco and Martin, Paula Moreno and Romero, Gema and Scherbakovsky, Stacey and Hernandez, Candido and Sainz, Maria and Martin, Nicolas J-P and Le Blevec, Audrey and Kreter, Bruce and Branch, Andrea D},
  title = {Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70275}
}
Kostenlos starten →